Clinical Trial Update: Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 pediatric trial evaluating alpha/beta CD19+ depleted haploidentical transplantation in combination with Zoledronic acid (Zometa) for multiple hematologi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Ewing Sarcoma
• Hodgkin Lymphoma
• Neuroblastoma
• Non-hodgkin Lymphoma
• Osteosarcoma
• Rhabdomyosarcoma

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 | Status: RECRUITING